Quantcast

Latest Perfluorocarbon Stories

2011-03-23 13:38:48

Exposure to perfluorocarbons associated with lower concentrations of the hormone estradiol A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that higher levels of perfluorocarbons (PFCs) in the body are associated with increased odds of having experienced menopause in women between 42 and 64 years old. Women in this age group with high levels of PFCs also had significantly lower concentrations of estrogen when...

2010-12-03 11:34:00

DURHAM, N.C., Dec. 3, 2010 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) (SIX Swiss Exchange: OXBT) today announced that the Company plans to report second quarter fiscal year 2011 financial results on Thursday, December 9, 2010. Oxygen's Chairman and CEO Chris Stern, and Chief Financial Officer Michael Jebsen, will host a conference call and live webcast to discuss the results on Friday, December 10, 2010 at 11 a.m. EST. To access the live teleconference dial...

2010-01-21 08:00:00

DURHAM, N.C., Jan. 21 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) chairman and CEO Chris Stern will preside over the NASDAQ Opening Bell on Friday, January 22, 2010. A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx starting at 9:20 a.m. eastern time. About Oxygen Biotherapeutics, Inc. Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in...

2010-01-13 13:59:00

DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that the company's common stock will begin trading on the NASDAQ Capital Market with the opening of trading on Friday, January 15, 2010. The shares will continue to trade under the symbol OXBT. In addition, company chairman and CEO Chris Stern will be in New York to ring the opening bell at the NASDAQ one week later on Friday, January 22. About Oxygen Biotherapeutics,...

2010-01-13 12:23:00

DURHAM, N.C., Jan. 13 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) chairman and CEO Chris Stern outlined plans for the introduction of new products during a presentation today at the OneMedForum 2010 investor conference in San Francisco. During the brief presentation, limited by conference organizers to 10 minutes per company, Stern said Oxygen Biotherapeutics, Inc. plans to launch four products in its cosmetics line during 2010. They include an eye...

2010-01-11 07:30:00

DURHAM, N.C., Jan. 11 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that company chairman and CEO Chris Stern will present at the OneMedForum 2010 investor conference in San Francisco on Wednesday, Jan. 13, 2010. The presentation, limited by conference organizers to 10 minutes per company, will be at 9:00 a.m. pacific time and will be webcast live. A link to the webcast will be available the day of the presentation at the following url:...

2009-11-30 07:30:00

DURHAM, N.C., Nov. 30 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced that the company has received $3 million from Vatea Fund as partial payment for the company's achievement of a milestone under the Securities Purchase Agreement dated June 8, 2009, as amended September 1, 2009. The milestone triggering this tranche was achieved in September, but the payment was only due by December 10. The Vatea Fund is expected to deliver the remaining $3...

2009-11-17 10:53:19

A new study indicates that major chemicals most often cited as leading causes of climate change, such as carbon dioxide and methane, are outclassed in their warming potential by compounds receiving less attention. Purdue University and NASA examined more than a dozen chemicals, most of which are generated by humans, and have developed a blueprint for the underlying molecular machinery of global warming. The results appear in a special edition of the American Chemical Society's Journal of...

2009-11-17 07:30:00

DURHAM, N.C., Nov. 17 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the company has begun shipping Dermacyte(TM) Oxygen Concentrate Gel to customers who have pre-ordered through the BuyDermacyte.com website. The shipments, which are going out today, cover orders received through early November. "This is a major milestone event for our company - actually shipping a product to customers and generating revenue as a result," said Chris...

2009-10-20 07:30:00

DURHAM, N.C., Oct. 20 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced its expanded product development plan. The new clinical development pipeline now encompasses seven indications for the Oxycyte(TM) emulsion: Traumatic Brain Injury, Carbon Monoxide Poisoning, Surgical Iatrogenic Air Embolism, Spinal Cord Injury, Organ Preservation, Decompression Sickness, and Sickle Cell Crisis. Oxycyte is the Company's perfluorocarbon (PFC)...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related